Cargando…
P1290: UPFRONT ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION CAN PROVIDE SURVIVAL BENEFIT VERSUS HYPOMETHYLATING AGENT IN MYELODYSPLASTIC SYNDROME WITH INCREASED BLASTS I (MDS-IBI)
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430435/ http://dx.doi.org/10.1097/01.HS9.0000972048.53278.90 |
| _version_ | 1785090963293601792 |
|---|---|
| author | Runzhi, MA Zhen, Sisi Wang, Jieru Liu, LI Jiang, Erlie Han, Mingzhe Xu, Zefeng Xiao, Zhijian Feng, Sizhou |
| author_facet | Runzhi, MA Zhen, Sisi Wang, Jieru Liu, LI Jiang, Erlie Han, Mingzhe Xu, Zefeng Xiao, Zhijian Feng, Sizhou |
| author_sort | Runzhi, MA |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430435 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104304352023-08-17 P1290: UPFRONT ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION CAN PROVIDE SURVIVAL BENEFIT VERSUS HYPOMETHYLATING AGENT IN MYELODYSPLASTIC SYNDROME WITH INCREASED BLASTS I (MDS-IBI) Runzhi, MA Zhen, Sisi Wang, Jieru Liu, LI Jiang, Erlie Han, Mingzhe Xu, Zefeng Xiao, Zhijian Feng, Sizhou Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430435/ http://dx.doi.org/10.1097/01.HS9.0000972048.53278.90 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Runzhi, MA Zhen, Sisi Wang, Jieru Liu, LI Jiang, Erlie Han, Mingzhe Xu, Zefeng Xiao, Zhijian Feng, Sizhou P1290: UPFRONT ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION CAN PROVIDE SURVIVAL BENEFIT VERSUS HYPOMETHYLATING AGENT IN MYELODYSPLASTIC SYNDROME WITH INCREASED BLASTS I (MDS-IBI) |
| title | P1290: UPFRONT ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION CAN PROVIDE SURVIVAL BENEFIT VERSUS HYPOMETHYLATING AGENT IN MYELODYSPLASTIC SYNDROME WITH INCREASED BLASTS I (MDS-IBI) |
| title_full | P1290: UPFRONT ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION CAN PROVIDE SURVIVAL BENEFIT VERSUS HYPOMETHYLATING AGENT IN MYELODYSPLASTIC SYNDROME WITH INCREASED BLASTS I (MDS-IBI) |
| title_fullStr | P1290: UPFRONT ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION CAN PROVIDE SURVIVAL BENEFIT VERSUS HYPOMETHYLATING AGENT IN MYELODYSPLASTIC SYNDROME WITH INCREASED BLASTS I (MDS-IBI) |
| title_full_unstemmed | P1290: UPFRONT ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION CAN PROVIDE SURVIVAL BENEFIT VERSUS HYPOMETHYLATING AGENT IN MYELODYSPLASTIC SYNDROME WITH INCREASED BLASTS I (MDS-IBI) |
| title_short | P1290: UPFRONT ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION CAN PROVIDE SURVIVAL BENEFIT VERSUS HYPOMETHYLATING AGENT IN MYELODYSPLASTIC SYNDROME WITH INCREASED BLASTS I (MDS-IBI) |
| title_sort | p1290: upfront allogeneic hematopoietic stem cell transplantation can provide survival benefit versus hypomethylating agent in myelodysplastic syndrome with increased blasts i (mds-ibi) |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430435/ http://dx.doi.org/10.1097/01.HS9.0000972048.53278.90 |
| work_keys_str_mv | AT runzhima p1290upfrontallogeneichematopoieticstemcelltransplantationcanprovidesurvivalbenefitversushypomethylatingagentinmyelodysplasticsyndromewithincreasedblastsimdsibi AT zhensisi p1290upfrontallogeneichematopoieticstemcelltransplantationcanprovidesurvivalbenefitversushypomethylatingagentinmyelodysplasticsyndromewithincreasedblastsimdsibi AT wangjieru p1290upfrontallogeneichematopoieticstemcelltransplantationcanprovidesurvivalbenefitversushypomethylatingagentinmyelodysplasticsyndromewithincreasedblastsimdsibi AT liuli p1290upfrontallogeneichematopoieticstemcelltransplantationcanprovidesurvivalbenefitversushypomethylatingagentinmyelodysplasticsyndromewithincreasedblastsimdsibi AT jiangerlie p1290upfrontallogeneichematopoieticstemcelltransplantationcanprovidesurvivalbenefitversushypomethylatingagentinmyelodysplasticsyndromewithincreasedblastsimdsibi AT hanmingzhe p1290upfrontallogeneichematopoieticstemcelltransplantationcanprovidesurvivalbenefitversushypomethylatingagentinmyelodysplasticsyndromewithincreasedblastsimdsibi AT xuzefeng p1290upfrontallogeneichematopoieticstemcelltransplantationcanprovidesurvivalbenefitversushypomethylatingagentinmyelodysplasticsyndromewithincreasedblastsimdsibi AT xiaozhijian p1290upfrontallogeneichematopoieticstemcelltransplantationcanprovidesurvivalbenefitversushypomethylatingagentinmyelodysplasticsyndromewithincreasedblastsimdsibi AT fengsizhou p1290upfrontallogeneichematopoieticstemcelltransplantationcanprovidesurvivalbenefitversushypomethylatingagentinmyelodysplasticsyndromewithincreasedblastsimdsibi |